Evidence map›Paper›PMID 41933456›Full record

Trial reportJournal of cachexia, sarcopenia and muscle2026

Skeletal Muscle and Circulating microRNAs Adaptations to 12-Week HIIT With or Without L-Citrulline in Obese Older Adults.

Alexandre Mercier-Guery, Marjorie Millet, Martine Croset, Vincent Marcangeli, Maude Dulac, Livia P Carvalho, Guy Hajj-Boutros, Pierrette Gaudreau, José A Morais, Gilles Gouspillou and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alexandre Mercier-GueryINSERM UMR 1033, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0002-7515-9353
Marjorie MilletINSERM UMR 1033, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Lyon, France.
Martine CrosetINSERM UMR 1033, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Lyon, France.
Vincent MarcangeliDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.
Maude DulacDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.
Livia P CarvalhoÉcole de Réadaptation, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Guy Hajj-BoutrosDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.
Pierrette GaudreauDépartement de Médecine de l'Université de Montréal, Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CRCHUM), Université de Montréal, Montréal, Québec, Canada.
José A MoraisDepartment of Medicine, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
Gilles GouspillouDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.
Philippe NoirezDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.
Jean Charles RousseauINSERM UMR 1033, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Lyon, France.
Roland ChapurlatRheumatology Department, Hôpital E. Herriot, Hospices Civils de Lyon, Lyon, France.
Mylène Aubertin-LeheudreDépartement des sciences de l'activité physique, Groupe de recherche en Activité Physique Adaptée, Faculté des Sciences, UQAM, Montréal, Québec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-intensity interval training (HIIT) with or without L-citrulline (CIT) oral supplementation improves body composition, functional capacities and muscle health in obese older adults, potentially through microRNA-driven regulation. We aimed to (1) investigate the impact of a 12-week HIIT on the expression level of microRNAs in vastus lateralis muscle biopsies and serum of obese older adults and (2) assess whether the differential expression level of microRNAs was associated with clinico-biological adaptations to HIIT and provide potential biomarkers of HIIT response.

methodsIn this secondary exploratory analysis of a double-blind randomized trial, 36 women and 32 men (67.2 ± 5.2 years) following 12 weeks HIIT randomized in two groups were supplemented daily with CIT (HIIT-CIT, n = 37) or with placebo (HIIT-PLA, n = 31). Phenotypic variables, serum parameters, muscle biopsies and subcutaneous abdominal adipose tissue outcomes were collected pre-intervention and postintervention. To assess the microRNA profile, the miRNome of muscle biopsy and serum was analysed using next generation sequencing in participants' subsets (n = 13). The microRNAs' differential expression level was analysed pre-intervention and postintervention by TaqMan-real-time qPCR in 68 participants.

resultsThe expression of myo-microRNAs (miR-133a, b, -1, -206) and muscle-related-microRNAs (miR-499, -208) was not altered following HIIT with or without CIT. In HIIT-PLA, HIIT-CIT and subgroups (based on sex, age, body mass index, dynapenic status), the change in muscle (miR-504-5p, -744-5p, -151a-3p, -106b-5p, -127-5p) and circulating (miR-4433b-5p, 151a-3p, -744-5p, 483-3p, -106b-5p, -484) microRNA levels was associated with changes of clinico-biological parameters. Supplementing HIIT with CIT decreased the muscle miR-504-5p level (p = 0.022), correlating with lower body fat, improved functional capacities, muscle power and increased IGF-1 level (r = -0.6, p < 0.05). MiR-744-5p expression increased in dynapenic participants (p = 0.04), associated with lean mass gain (r = 0.50, p < 0.05), while miR-151a-3p downregulation in men's muscle (p = 0.01) was associated with better insulin sensitivity (HOMA-IR, r = 0.57, p = 0.05). In serum, miR-151a-3p upregulation in women (p = 0.01) correlated with improved muscle power and lower circulating leptin levels, while miR-4433b-5p downregulation (p = 0.001) was linked to reduced fat mass, lean mass gain and enhanced functional capacity. The downregulation of miR-106b-5p (p = 0.05) was associated with a higher adiponectin level and a better score of the 4-m walking test (p = 0.05).

conclusionHIIT did not impact the expression level of myo-microRNAs and muscle-related microRNAs but induced changes in muscle-nonspecific microRNAs in muscle biopsy and serum. Modulations of microRNAs in muscle (miR-504-5p, -744-5p) and serum (miR-151a-3p, -4433b-5p, -106b-5p) were associated with HIIT's beneficial effects, suggesting their role in the HIIT effects and their potential as candidate biomarkers for response.

Indexed as

Circulating MicroRNACitrullineHigh-Intensity Interval TrainingMicroRNAsMuscle, SkeletalObesityAdaptation, PhysiologicalAgedBiomarkersDouble-Blind MethodFemaleHumansMaleBiomarkersCirculating MicroRNACitrullineMicroRNAsadipose tissueaerobic exerciseagingbiomarkersdynapeniagene expressionnext‐generation sequencingnutritional supplementsqPCRsarcopenia

Identifiers

PMID41933456
PMCPMC13051928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.